Agenus Inc.

Healthcare

NASDAQ:AGEN · NASDAQ Capital Market

Market Cap $127.84M Beta 1.57 P/E (TTM) 1.9

$3.30 -2.65%

-$0.09 today

52W Low $2.71High $7.34

Vol 0.50M · Avg 0.83M

EPS (TTM)$1.70

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-29.79%

Period High

$7.06

Period Low

$2.77

Latest

$3.30

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Opus Genetics, Inc.

NASDAQ:IRD

$328.84M

Zentalis Pharmaceuticals, Inc.

NASDAQ:ZNTL

$266.95M

Fate Therapeutics, Inc.

NASDAQ:FATE

$240.11M

Turn Therapeutics Inc.

NASDAQ:TTRX

$180.07M

TuHURA Biosciences, Inc.

NASDAQ:HURA

$147.74M

Acumen Pharmaceuticals, Inc.

NASDAQ:ABOS

$143.56M

Seer, Inc.

NASDAQ:SEER

$94.57M

Pliant Therapeutics, Inc.

NASDAQ:PLRX

$69.97M

Inovio Pharmaceuticals, Inc.

NASDAQ:INO

$58.95M

VistaGen Therapeutics, Inc.

VTGN

$18.88M

What is the latest AGEN filing?

The latest filing shown is 4 dated Jun 2, 2026.

How many recent filings does AGEN have?

Intrinsic Alpha currently shows 20 recent filings for AGEN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.